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LIGHT HYPERSENSITIVITY
A SIMPLIFIED OFFICE PROCEDURE FOR DIAGNOSIS OF CONTACT PHOTODERMATITIS*
WILLIAM L. CURWEN, M.D.f AND OTIS F. JILLSON, M.D4
Many substances applied externally to the skin
have the capacity to render the treated area of
skin hypersensitive to light. Such light hyper-
sensitivity, known as contact photodermatitis,
is of two types, phototoxic and photoallergic.
A well-known example of phototoxic dermatitis
is berloque dermatitis. Photoallergic dermatitis
of contact origin was noted by Epstein (1) in
1942 and was ably described by Sams (2) in 1955,
when he wrote about his altered skin response to
shalmire perfume and sunlight.
A phototoxic reaction is a skin response of
exaggerated sunburn. It arises from the inter-
action between a photocontactant in the skin
and light energy of specific wave lengths. The
reaction is limited to the area of irradiated photo-
contactant. To be active the photocontactant
must be capable of absorbing some of the ir-
radiating wave lengths. Therefore, the exciting
light energy must include the absorption spec-
trum of the photocontactant.
A photoallergic reaction is different. It may be
delayed. It may manifest itself by the appear-
ance of any combination of erythema, papules,
papulo-urticarial lesions, or eczema. The response
is not limited sharply to the area of irradiated
photocontactant. It needs no specific wave
length of light energy (3) and therefore may be
initiated by any erythema-producing radiation.
To date, common methods of office testing for
contact phototoxic agents have usually included
a mercury vapor light source. If the action spec-
trum of the photosensitizer does not coincide
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with the emitted spectral lines of the vapor lamp,
the photocontactant is missed. Therefore, in this
study, a continuous spectrum light source with
appropriate bandpass filters was used. Further,
current office routines of testing for contact
photodermatitis, while sometimes satisfactory
in eliciting simple phototoxic dermatitis, often
fail to help the clinician diagnose the contact
origin of the photoallergic dermatitis through
lack of sufficient quantity in the testing irradia-
tion (4). Because allergic contact photodermatitis
is becoming more commonly diagnosed, either
due to increased awareness on the part of the
clinician or because of an actual increase in the
frequency of the disease, a more reliable method
is needed to help establish the diagnosis. The
purpose of this paper is to describe a simple
office photopatch test procedure for use in
diagnosis of both the phototoxic and photo-
allergic phases of contact photodermatitis.
MATERIALS
1. A carbon arc light is used for a continuous
spectrum source of light energy. National Car-
bon Company's "B. Therapeutic" carbons are
used for their characteristic of high emission in
the ultraviolet region.
2. Corning Glass Works' colored glass filters
are used to delineate specific bandpass trans-
missions. For the survey testing, filter 9863 is
used in routine survey work (Fig. 1). It will
transmit the entire ultraviolet spectrum and block
the visible and infrared spectra.*
3. The light source and filters are housed in an
inexpensive simple lamp made by Bausch &
Lomb Company (Fig. 2). This stock lamp has
added to it as an exit slit a narrow diameter tube.
This tube serves three purposes. First, it contains
a slot which will hold the filter controlling the
* Other filters may be used subsequently to test
for more specific action spectra in phototoxic
dermatoses: a. 5860 transmits a narrow bandpass
in the Wood's light region; b. $5031 transmits
monochromatic blue—extending into the long
invisible ultraviolet region; c. 3384 transmits
visible light only; and d. Single thickness window
glass transmits ultraviolet above 3100 A and
visible light. Filters used are polished stock
thickness, 2 inches b 2 inches.
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LIGHT TRANSMISSION OF CORNING FILTERS
A Wavelength) in mp.
1= Relative Effective ( >15%) TransmissIon Of Corning FIlter
FIG. 1. A schematic representation of transmission characteristic of wave length filters useful in
locating action spectra of phototoxie dermatoses.
quality of radiation. Second, it has a nonheat-
conducting material at the end which is placed
gently against the subject's skin, thus main-
taining a constant distance of 63 inches from the
radiation source; the quantity of energy delivered
to the skin is theretore a function only of time.
Third, it prevents stray radiation and localizes
the delivered light to a small area of skin.
PRoennuRa
1. The procedure used involves irradiating an
area of skin previously prepared by application
of the suspected photocontactant in a manner
to provoke both phototoxic and photoallergic
phenomena that may be present.
2. A phototoxic response is elicited by ir-
radiating a prepared patch test site with just
less than the minimal erythema dose (MED.)
of ultraviolet light. For this procedure, the defi-
nition of this term M.E.D. is that time of irradia-
tion on normal skin required to produce a faintly
perceptible erythema 24 hours following ir-
radiation.
3. A photoallergic response is provoked by
irradiating a second prepared patch test site
with S times the M.E.D. of ultraviolet. We refer
to this as the delayed erythcma dose or D.E.D.
(5).
Our procedure for this type of photopatch
testing extends over a four-day period:
FIG. 2. Mechanical Feed Are Illuminator with
filter holding exit slit in place. Available from
Bausch & Lomb Co., Rochester, New York.
Day 1: a. Triplicate closed patch tests of the
suspected photocontactant are placed on the
patient's back. b. An area of adjacent skin is
washed with acetone* and irradiated to deter-
mine the M.E.D. Graded exposures of 15, 30,
* Prior to the MEl). determination, the skin is
washed with acetone to remove light absorbing
sweat and surface lipids.
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FIG. 3. (upper) Photopatch test procedure on first day. Suspected photocontactant on the left, M.E.D.
irradiation on the right.
Fin. 4. (lower) Photopatch test procedure on second day. MED. is 45 seconds. Two of the patch test
sites are irradiated after washing with acetone, one with just. less than the MEl)., the other with the
DE.D.
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Fin. 5. Photopatch test procedure on third day. Phototoxic reaction is apparent at sub MED.
irradiated pstch test site.
Fin. 6. Eczematous photoallergic reaction noted on fourth day at D.E.D. irradiated patch test site.
Note negative control on left.
45, 60 seconds are done and marked for reference with acetone,* and that area irradiated with just
for the following day (Fig. 3). less than one MED. of ultraviolet already estab-
Day 2: a. The M.E.D. is observed; this is that * Photocontactants have the capacity to absorb
area of timed irradiation having the faintest ultraviolet light energy. Excess photocontactant
left on the skin may therefore act as a sunscreen,erythema. b. One of the three closed patch tests blocking the testing light from the preparedis rcmoved, the excess contactant washed off epidermis.
____
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FIG. 7. Papular photoallergic reaction most marked at 1).E.D. irradiated patch test site on fourth
day, or 48 hours after irradiation.
lished for that particular patient on that par-
ticular site. c. A second of the three closed patch
tests is removed, the excess contactant washed
off with acctonc,t and the area irradiated with
the D.E.D., or 8 times the MED. (Fig. 4).
Day 3: a. The third of the three closed patches
is removed. This is the control. The MED. and
D.E.D. irradiated patch test sites are compared
with it and with each other.
Day 4: a. The control and irradiated patch
test sites are again compared. b. Areas of primary
photodermatitis are observed for flare.
RESULTS
1. A phototoxic reaction is present when there
is a sharply demarcated erythema at the M.E.D.
irradiated patch test site and none at the control
area. This is usually most marked 24 hours after
irradiation of the prepared patch test sites
(Fig. 5).
2. a. A photoallergie reaction is present when
there is an eezematous or papular response at the
D.E.D. irradiated patch test site but none in the
control site (Figs. 6 and 7). The response is
frequently delayed, appearing 48 hours after
irradiation of the prepared patch test site. b.
The original site of contact photoallergic disease
may be flared by the testing irradiation.
SUMMARY
A simplified office procedure to aid in the
diagnosis of contact dermatitis has been de-
scribed. The method is necessary to detect and
separate both the phototoxie and photoallergie
phases which may be present in any given ease
of contact photodermatitis.
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DISCUSSION
DR. FARRINGTON DANIELS, JR. (Portland,
Oregon): The authors are to be congratulated
on their fine contribution in this difficult field. I
think since about the time Finsen got the Nobel
Prize, dermatologists have been trying to con-
vince people that we should use carbon ares,
with very little success. I hope that Dr. Curwen
will send 50 reprints to each of the manufac-
1.-I
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turers of mercury arc ultraviolet lamps, so that
they can be alerted to our continuing feeling
that the carbon arc is necessary rather than any
modification of the mercury arc. I would like to
ask Dr. Curwen one question, which is: Why
has he decided to place so much reliance on
quantitative differences in time of exposure
when in the past most reliance has been placed
on the use of different wave lengths obtained by
filters to identify the abnormal responses?
DR. KATE MILLER (Flushing, N. Y.): I would
like to ask the speaker whether this test in any
way helps us to differentiate lupus erythematosus
from polymorphous light eruption.
DR. HARm' L. ARNOLD, JR. (Honolulu,
Hawaii): I would like to compliment Dr. Curwen
on the beautiful clear presentation. It was
like a lot of simple things which required any-
thing but simple mental processes to elucidate.
I would like to ask one question particularly,
that is, why they don't put in the beam some-
thing to duplicate the atmospheric cut-off,
instead of going all the way up to 2600 or 2800
Angstroms?
DR. STEPHEN ROTHMAN (Chicago, Ill.): I
wonder if the criteria here presented for "photo-
toxic" and "photoallergie" reactions are suffi-
ciently distinct to work with. Theoretically, of
course, the term "photoallergie" should be re-
served for reactions where an antibody mecha-
nism can be demonstrated or at least suspected.
DR. EUGENE T. D. BEENSTRIN (New York,
N. Y.): I must admit to my shame that it was
not until about four days ago that I saw the first
ease of photosensitivity and it was a patient who
exhibited all the attributes of lupus erythemato-
sus to such an extent that he was treated by five
dermatologists previously for lupus. Now it seems
to me that the diagnosis can be established only
on histopathologie grounds, because the histology
differs in respect that the pilosebaeeous appa-
ratus is not involved in photosensitivity. There
is such a similarity to lupus erythematosus dis-
eoides that one must be more on guard to draw
the distinction between the discoid form and
photosensitivity.
DR. MARION B. SULZBERGER (New York,
N. Y.): I really want to ask the same question
that Dr. Rothman asked. How did these different
tests distinguish between photoallergy and photo-
toxicity? According to my concept, it is quite
generally held that phototoxic reactions are those
in which the radiant energy produces substances
or changes which are not allergens but which are
irritating or damaging to the tissues without
any previous sensitization mechanism being
required. Photoallergic reactions are those in
which radiant energy hitting the biologic systems
or constituents of the tissues or the surfaces, pro-
duces substances or liberates substances which are
allergenic and produce reactions in the tissues
on an immunologic basis after a specific sensitila-
tion has taken place.
I would like to know- how these tests of Drs.
Curwen and Jillson distinguish between those
two mechanisms.
DR. WILLIAM L. CURWEN (in closing): I
should like to thank the diseussers for their
comments. The main problem seems to be the
differentiation between phototoxieity and photo-
allergy. Actually, Dr. Sulzberger analyzed this
very neatly. A phototoxie reaction is elicited by
absorption of specific wavelengths of light to
produce a sharply demarcated increased sunburn
reaction; this does not fit in our current concept
of allergic phenomena.
On the other hand, the photoallergic reaction,
ably described by Dr. Epstein in Wisconsin in
1942, when he commented on Dr. Sams' altered
reactivity to bergamot oil, is not necessarily
produced by any specific wavelength and fre-
quently requires much more energy to elicit
the response.
Hence in this particular test we are using n
subminimal erythema dose to elicit phototoxicity;
we produce an erythcma. In the absence of photo-
toxicity, no photoallergic response is forthcoming.
As basis for the delayed erythema dose, Drs.
Cahn, Epstein, and Levy pointed out that in-
tense irradiation of any wavelength that will
produce erythema is frequently needed to elicit
a photoallergie response. This response, which is
often delayed, is not sharply demarcated at the
patch test site, is manifested by a papular or
cezematous reaction appearing in the delayed
erythema provoked by the patch testing pro-
cedure, and, lastly, may include distal flares of
primary photoallergic disease.
